fluorouracil

Generic: fluorouracil

Labeler: taro pharmaceuticals u.s.a., inc.
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name fluorouracil
Generic Name fluorouracil
Labeler taro pharmaceuticals u.s.a., inc.
Dosage Form CREAM
Routes
TOPICAL
Active Ingredients

fluorouracil 50 mg/g

Manufacturer
Taro Pharmaceuticals U.S.A., Inc.

Identifiers & Regulatory

Product NDC 51672-4118
Product ID 51672-4118_170232f3-4992-1e1a-e063-6394a90a38e9
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA090368
Listing Expiration 2026-12-31
Marketing Start 2010-03-05

Pharmacologic Class

Established (EPC)
nucleoside metabolic inhibitor [epc]
Mechanism of Action
nucleic acid synthesis inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 516724118
Hyphenated Format 51672-4118

Supplemental Identifiers

RxCUI
105583
UNII
U3P01618RT
NUI
N0000000233 N0000175595

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fluorouracil (source: ndc)
Generic Name fluorouracil (source: ndc)
Application Number ANDA090368 (source: ndc)
Routes
TOPICAL
source: ndc

Resolved Composition

Strengths
  • 50 mg/g
source: ndc
Packaging
  • 1 TUBE in 1 CARTON (51672-4118-2) / 25 g in 1 TUBE
  • 5 g in 1 TUBE (51672-4118-5)
  • 1 TUBE in 1 CARTON (51672-4118-6) / 40 g in 1 TUBE
source: ndc

Packages (3)

Ingredients (1)

fluorouracil (50 mg/g)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["TOPICAL"], "spl_id": "170232f3-4992-1e1a-e063-6394a90a38e9", "openfda": {"nui": ["N0000000233", "N0000175595"], "unii": ["U3P01618RT"], "rxcui": ["105583"], "spl_set_id": ["acca0036-f19c-459b-9dfc-9592f1cd588d"], "pharm_class_epc": ["Nucleoside Metabolic Inhibitor [EPC]"], "pharm_class_moa": ["Nucleic Acid Synthesis Inhibitors [MoA]"], "manufacturer_name": ["Taro Pharmaceuticals U.S.A., Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (51672-4118-2)  / 25 g in 1 TUBE", "package_ndc": "51672-4118-2", "marketing_start_date": "20170317"}, {"sample": false, "description": "5 g in 1 TUBE (51672-4118-5)", "package_ndc": "51672-4118-5", "marketing_start_date": "20170317"}, {"sample": false, "description": "1 TUBE in 1 CARTON (51672-4118-6)  / 40 g in 1 TUBE", "package_ndc": "51672-4118-6", "marketing_start_date": "20170317"}], "brand_name": "Fluorouracil", "product_id": "51672-4118_170232f3-4992-1e1a-e063-6394a90a38e9", "dosage_form": "CREAM", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "51672-4118", "generic_name": "Fluorouracil", "labeler_name": "Taro Pharmaceuticals U.S.A., Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fluorouracil", "active_ingredients": [{"name": "FLUOROURACIL", "strength": "50 mg/g"}], "application_number": "ANDA090368", "marketing_category": "ANDA", "marketing_start_date": "20100305", "listing_expiration_date": "20261231"}